A retrospective case-control study to estimate the sensitivity and specificity of a pharmacogenetic marker ( HLA-B 5701) in subjects with and without hypersensitivity to abacavir.

Trial Profile

A retrospective case-control study to estimate the sensitivity and specificity of a pharmacogenetic marker ( HLA-B 5701) in subjects with and without hypersensitivity to abacavir.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2007

At a glance

  • Drugs Abacavir (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions; Pharmacogenomic
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 01 Aug 2007 Status changed from in progress to completed.
    • 05 May 2007 Interim results have been reported.
    • 16 Feb 2007 Status changed from recruiting to in progess.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top